A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months

NCT07036159 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
238
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline